Sun Pharma and Moebius Medical publish clinical and mechanistic data on non-opioid knee…
Phase 2b study and supporting research highlight MM-II’s potential in symptomatic knee osteoarthritis; new findings presented at…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
Pharma and healthcare deals in Q1 2025 remain stable amid shift to scalable global models
Grant Thornton Bharat reports 71 transactions totalling USD 2.6 billion in Q1 2025, with investor activity focused on mid-market…
DHL Express and Sai Life Sciences partner to cut emissions in pharma logistics with GoGreen Plus
Sai Life Sciences adopts DHL’s GoGreen Plus service to reduce greenhouse gas emissions by 90 per cent using sustainable aviation…
PHARMAP 2025 brings together global pharma leaders to discuss innovation and drug safety
Chakravarthi AVPS delivers special address on drug safety and moderates key discussion at PHARMAP 2025, shaping the future of…
Trump tariffs on the pharmaceutical sector. A new twist- the US department of commerce initiates a…
Ashwin Sapra highlights how the US Section 232 investigation into pharma imports marks a significant escalation in Trump-era trade…
Global divide emerges among physicians over patient choice in biologics vs. biosimilars, reveals…
GlobalData survey uncovers stark regional differences in physician support for patient involvement in choosing between biologics…
PADCEV™ (enfortumab vedotin) now available in India for locally advanced or metastatic urothelial…
Enfortumab vedotin is now available for patients who received prior platinum-containing chemotherapy and a PD-1/L1 inhibitor
Syngene collaborates with biotech firm to develop bile acid modulator for cholestatic disease…
On the occasion of World Liver Day, Jayashree Aiyar, Chief Scientific Officer, Syngene International shared her insights into a…
AbbVie introduces Venetoclax in India for treatment of AML and CLL
On AML World Awareness Day, AbbVie announces its entry into the Indian oncology market with Venetoclax, targeting treatment gaps…
Sanofi-Regeneron’s Dupixent gets FDA’s nod for skin condition
FDA clears Dupixent for chronic spontaneous urticaria in patients aged 12 and above, expanding its use in immune-related skin…
Innovent’s Sycume to transform thyroid eye disease treatment landscape in China and Asia: GlobalData
Sycume becomes China’s first approved IGF-1R monoclonal antibody for thyroid eye disease, offering a new treatment option after…
AI does not just make clinical trials faster; it makes them smarter
Santhosh A F, VP, Asia Pacific South & India, Medidata highlights how AI is improving the efficiency and speed of the clinical…
A troubling new development in India’s QR code saga
Dr Avi Chaudhuri, a global expert on anti-counterfeiting has written extensively on the deficits of the recently mandated QR…
US FDA issues EIR for Lupin’s injectable facility in Nagpur
Lupin receives Establishment Inspection Report for injectable unit following US FDA inspection in June 2024
Venus Remedies’ VRP-034 receives QIDP designation from US FDA
The QIDP designation provides regulatory benefits, advancing efforts to combat antimicrobial resistance
India restricts use of Chlorpheniramine Maleate and Phenylephrine Hydrochloride FDC in children…
Manufacturers required to display warning on labels, inserts and promotional material following safety concerns
Glenmark to launch generic version of Adderall Tablets in the US market by May 2025
Company announces bioequivalent and therapeutically equivalent version of Mixed Salts of a Single Entity Amphetamine Product…
Pharma experts spotlight GenAI’s transformative role in life sciences
Leaders from GSK, L’Oréal Lifesciences, Sravathi AI, and GAVS discussed how generative AI is being applied for drug discovery,…
Shilpa Medicare receives CDSCO SEC Nod for IND Nor UDCA tablets for NAFLD treatment
Shilpa Medicare secures Subject Expert Committee approval for its novel therapy Nor Ursodeoxycholic Acid, following positive phase…
Sun Pharma appoints Shaik Barak Tulla as Senior Vice President
Shaik Barak Tulla to drive commercial planning and business acceleration at Sun Pharma with over 25 years of pharma industry…